Curasight A/S reports positive preclinical results with uTREAT® in aggressive brain cancer (glioblastoma) ...Middle East

PR Newswire - Economy
Preclinical studies show uTREAT® efffective in treating aggressive brain cancer Data supports strategy to move uTREAT® into clinical development for evaluation in patients with aggressive brain cancer COPENHAGEN, Denmark, June 7, 2023 /PRNewswire/ -- Curasight A/S ("Curasight" or "the...

Hence then, the article about curasight a s reports positive preclinical results with utreat in aggressive brain cancer glioblastoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Curasight A/S reports positive preclinical results with uTREAT® in aggressive brain cancer (glioblastoma) )

Apple Storegoogle play

Last updated :

Also on site :